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RESEARCH ARTICLE
Piscine orthoreovirus subtype 3 (PRV-3) 
causes heart inflammation in rainbow trout 
(Oncorhynchus mykiss)
Niccoló Vendramin1*† , Dhamotharan Kannimuthu2†, Anne Berit Olsen3, Argelia Cuenca1, 
Lena Hammerlund Teige2, Øystein Wessel2, Tine Moesgaard Iburg1, Maria Krudtaa Dahle4, Espen Rimstad2 
and Niels Jørgen Olesen1
Abstract 
Piscine orthoreovirus (PRV) mediated diseases have emerged throughout salmonid aquaculture. Three PRV subtypes 
are currently reported as causative agents of or in association with diseases in different salmonid species. PRV-1 
causes heart and skeletal muscle inflammation (HSMI) in Atlantic salmon (Salmo salar) and is associated with jaun-
dice syndrome in farmed chinook salmon (Oncorhynchus tshawytscha). PRV-2 causes erythrocytic inclusion body 
syndrome (EIBS) in coho salmon in Japan. PRV-3 has recently been associated with a disease in rainbow trout (Onco-
rhynchus mykiss) characterized by anaemia, heart and red muscle pathology; to jaundice syndrome in coho salmon 
(Oncorhynchus kisutch). In this study, we conducted a 10-week long experimental infection trial in rainbow trout with 
purified PRV-3 particles to assess the causal relationship between the virus and development of heart inflammation. 
The monitoring the PRV-3 load in heart and spleen by RT-qPCR shows a progressive increase of viral RNA to a peak, 
followed by clearance without a measurable change in haematocrit. The development of characteristic cardiac histo-
pathological findings occurred in the late phase of the trial and was associated with increased expression of CD8+, 
indicating cytotoxic T cell proliferation. The findings indicate that, under these experimental conditions, PRV-3 infec-
tion in rainbow trout act similarly to PRV-1 infection in Atlantic salmon with regards to immunological responses and 
development of heart pathology, but not in the ability to establish a persistent infection.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Piscine orthoreovirus (PRV) causes or are associated 
with emerging diseases in salmonid aquaculture. PRV 
belongs to the family Reoviridae, sub-family Spinareoviri-
nae, genus Orthoreovirus. It has a double stranded RNA 
genome consisting of 10 segments [1]. The virion has a 
double protein capsid with icosahedral symmetry and no 
envelope [1]. PRV resists cultivation in cell culture mon-
olayers, however, ex  vivo infection of naïve red blood 
cells has been demonstrated [2]. Efficient propagation of 
the virus relies on in vivo experimental challenge in sus-
ceptible fish.
Three subtypes of PRV have been reported and are 
denoted as PRV-1, PRV-2, and PRV-3. Subtypes 1 and 2 
have recently been identified as aetiological agents of dis-
ease in salmonids through infection with purified virus. 
PRV-1 causes heart and skeletal muscle inflammation 
(HSMI) in Atlantic salmon (Salmo salar) [3]. The disease 
was first diagnosed in 1999 in Norway [4, 5]; HSMI has 
also been reported in Scotland and Canada [6]. In Nor-
way, the causative relationship between PRV-1 and HSMI 
was demonstrated [3]. As the disease name implies, the 
major histopathological findings are in located in the 
heart and red skeletal muscle. Affected fish show pan-
carditis with epicarditis, mononuclear cell infiltrations in 
the atrium and spongy and compact layers of the cardiac 
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ventricle and necrotic cardiomyocytes. Severely affected 
fish also have red muscle inflammation [7].
PRV-2 was shown to cause erythrocytic inclusion body 
syndrome (EIBS) in coho salmon (Oncorhynchus kisutch) 
in 2016 [8] in Japan. The anaemic condition denoted as 
EIBS was first described in 1977 in rainbow trout [9] and 
in 1987 in chinook salmon from the Pacific Northwest 
of North America [10], however, as these occurrences 
predate the discovery of PRV-2, it remains unknown as 
to whether these historical EIBS cases are equivalent to 
the PRV-2 causing EIBS as diagnosed in Japan. To date, 
PRV-2 has not been reported outside of Japan.
PRV-3 was detected in 2013 following a thorough 
investigation of unexplained mortalities in young rain-
bow trout (Oncorhynchus mykiss) farmed in fresh water 
in Norway [11]. After detection of the virus, infection 
trials were conducted to assess its pathogenicity and the 
risk associated with its introduction to salmonid aqua-
culture in Europe. Those experimental trials showed that 
PRV-3 replicated in rainbow trout blood and efficiently 
transmitted to naïve host in a cohabitation trial, while 
its capacity of replicating in Atlantic salmon is limited 
[12]. The PRV-3 genome was sequenced and compared 
with PRV-1 showing that PRV-3 is more closely related to 
PRV-1 than PRV-2 [13].
PRV-3 antigenic properties were analyzed with anti-
bodies raised against homologous proteins of PRV-1. 
Western blot analysis of PRV-3 infected blood cells 
have demonstrated that polyclonal rabbit antisera raised 
against the homologous proteins of PRV-1 cross-reacted 
with the PRV-3 proteins σ1, σ3, σNS, µ1, µNS, and λ1 
[13].
The orthoreoviruses are, in general, ubiquitous in 
their respective niches. The mere detection of the virus 
is therefore not necessarily indicative of disease causal-
ity. For example, PRV-1 is present in almost every cohort 
of farmed Atlantic salmon in the marine phase [3] and 
PRV-3 was detected in non-diseased adult rainbow trout 
in Norway [14]. Recently the virus was detected in several 
European countries, including Scotland, Germany, Italy 
and Denmark both from disease outbreaks and asymp-
tomatic fish [13], the virus might also be associated with 
proliferative darkening syndrome (PDS) in brown trout 
[15]; finally PRV-3 was detected in clinically affected 
coho salmon in Chile [16, 17]. The main aim of our study 
was to demonstrate eventual causality between PRV-3 
infection in rainbow trout and development of cardiac 
lesions as observed in field cases and previous challenge 
experiments. Injection with blood from infected fish was 
used previously in infection trials, but did not prove that 
PRV-3 was in fact the sole causative agent of the disease, 
since other pathogens/viruses could be present in the 
sample.
In this study, we set out to demonstrate an eventual 
causality between a disease recently described in rain-
bow trout [11], and the associated Piscine orthoreovirus 
(PRV) [13]. To achieve this goal, PRV-3 was purified from 
experimentally infected rainbow trout blood and used in 
the challenge model previously developed to compare the 
infection progress and disease development with a con-
trol group injected with PRV-3 infected blood.
The viral RNA kinetics in the heart and spleen and PRV 
protein expression in erythrocytes were assessed, along 
with the development of heart pathology. In addition, the 
immune response was monitored through gene expres-
sion analysis and detection of PRV specific antibodies.
Materials and methods
Virus purification
The challenge material, consisting of purified PRV-3 
particles or PRV-3 infected blood, originated from 
intra peritoneal (i.p.) injected fish from a PRV-3 chal-
lenge trial described earlier [13]. PRV-3 particles (isolate 
NOR/060214) were purified from the PRV-3 infected 
blood (500 µL, Ct 19.7) exactly as stated in [13]. Fractions 
of 0.5 mL were collected using a syringe with a 23 G nee-
dle. The density of the fractions was determined by cross 
referencing to the refractive index [18]. The quantity of 
PRV-3 in the fractions was determined using RT-qPCR. 
Fractions with a density corresponding to that of PRV 
were chosen for dialysis. The purity of the samples was 
inspected by transmission electron microscopy (TEM) 
and analyzed by Next Generation Sequencing (NGS) as 
described by Dhamotaran et al. [13].
Experimental challenge
Rainbow trout were obtained from eyed eggs provided by 
a Danish commercial fish farm officially registered free of 
IPNV, IHNV, VHSV and bacterial kidney disease (BKD). 
After iodophor disinfection, the eggs were hatched and 
fish were grown in the wet laboratory facilities of the 
European Union Reference Laboratory for fish disease 
(EURL, Copenhagen, Denmark) using recirculated tap 
water disinfected by UV light. Before infection, the spe-
cific pathogen free (SPF) rainbow trout were moved into 
the high containment infection facility with fresh water 
at a constant temperature of 12 °C ± 1 °C. Each tank was 
supplied with flow-through UV disinfected water (1 full 
water exchange per day), furthermore one recirculating 
unit (EHEIM Professional 4+) was added to each tank to 
increase water quality and reduce water usage.
A total of 500 SPF rainbow trout of 10  g in average 
were kept in tanks with 5  L/h flow-through fresh water 
renewal using the following conditions: 12  °C ± 1  °C, 
L:D 12:12, stocking density below 60 kg/m3, and feeding 
of 1.5% of biomass/day. The fish were divided into three 
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groups: Negative control; purified PRV-3 particles and 
positive control PRV-3 infected blood.
In order to have comparable biomass in the different 
groups, the negative control group of 500  Lts capac-
ity accommodated 300 rainbow trout, the two experi-
mental tanks accommodating fish challenged with 
purified PRV-3 particles and positive controls were 180 
Lts accommodating 100 rainbow trout each. In all tanks 
the ratio between injected (shedders) and cohabitants 
was 50:50. To set up the cohabitation trial, shedder fish 
were anaesthetized by immersion in water containing 
benzocaine (80 mg/L water), and then i.p. injected with 
0.1 ml of challenge or mock inoculum. The PRV-3 RNA 
load in the infected blood inoculum was Ct 26.3 per 
5 µL; whereas in the purified viral particle inoculum the 
PRV-3 load was assessed as Ct 32.7 per 5 µL. Mock infec-
tion with blood from naïve fish (tested negative for PRV-
3) diluted in L-15 medium was performed in the same 
manner on 50% of the negative control fish. Injected fish 
were marked by adipose fin clipping. Sampling took place 
at 2, 4, 6, 8, 10 weeks post-challenge (wpc) and included 
six shedders and six cohabitants in the exposed tanks, 
whereas 2 mock injected fish and 2 negative control 
cohabitants where sampled. Sampling specifics are pro-
vided in Table 1.
Sampling
Upon sampling, fish were euthanized with benzocaine 
(800 mg/L). Blood was collected from the caudal vein in 
heparinized tubes (Kruuse ltd UK). Heparinized blood 
was centrifuged (130 g for 10 min) and plasma and blood 
cells were separated. Blood was used for Western blot 
(WB) and plasma for assessing specific antibody. An ali-
quot of heparinized blood was centrifuged (12 000 g for 
5  min) in glass microhematocrit tubes (Vitrex Medical 
A/S) with specific centrifuge (Nüve) and haematocrit 
(hct) assessed visually with specific scale.
Table 1 Design of the experimental trial 
a In addition 9 fish were collected prior to exposure and investigated for presence of PRV-3 and heart histopathology.
Group Number of fish Trial 
length 
(weeks)
Sampling time points 
(weeks post-challenge-
wpc)a
Fish sampled 
per time point
Samples Analysis
Negative control 150 mock injected 10 2, 4, 6, 8, 10 2 Blood Antibody detection
Heart Virus qPCR; CD4 CD8
Spleen Virus qPCR; IFN
Organs Histopathology
150 cohabitants 10 2, 4, 6, 8, 10 2 Blood WB—antibody 
detection—Hct
Heart Virus qPCR; CD4 CD8
Spleen Virus qPCR; IFN
Organs Histopathology
Purified PRV-3 particles 50 purified PRV-3 injected 10 2, 4, 6, 8, 10 6 Blood Antibody detection
Heart Virus qPCR; CD4 CD8
Spleen Virus qPCR
Organs Histopathology
50 cohabitants 10 2, 4, 6, 8, 10 6 Blood WB—antibody 
detection—Hct
Heart Virus qPCR; CD4 CD8
Spleen Virus qPCR; IFN
Organs Histopathology
Positive control 50 PRV-3 infected blood 
injected
10 2, 4, 6, 8, 10 6 Blood Antibody detection
Heart Virus qPCR; CD4 CD8
Spleen Virus qPCR
Organs Histopathology
50 cohabitants 10 2, 4, 6, 8, 10 6 Blood WB—antibody 
detection—Hct
Heart Virus qPCR; CD4 CD8
Spleen Virus qPCR; IFN
Organs Histopathology
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The heart was cut in two equal halves along the mid-
sagittal axis; one half was stored in 10% neutral-buffered 
formalin for histopathological evaluation, and the other 
half was divided into two aliquots: one was stored in 
 RNALater® (ThermoFisher Scientific Inc, USA) for gene 
expression analysis (CD4 and CD8) and one was stored 
in RLT buffer (© QIAGEN) for quantifying viral RNA. 
The spleen was divided into three aliquots: one was 
stored in 10% neutral-buffered formalin, one was stored 
in  RNALater® (ThermoFisher Scientific Inc,) for gene 
expression analysis and one was stored in RLT buffer 
(QIAGEN) for quantifying viral RNA. Gill, liver, pancreas 
and pyloric caeca, distal intestine, red and white muscle, 
mid kidney were also collected and stored in 10% neu-
tral-buffered formalin for histopathological evaluation.
Quantification of PRV-3 in the heart and spleen
RT-qPCR was performed on RNA purified from fish tis-
sue. After processing the sample with Tissue Lyzer (QIA-
GEN, Hilden, Germany), total RNA was isolated using 
QIAcube and the RNeasy Mini Kit (QIAGEN) according 
to the manufacturer’s recommendations.
RT-qPCR was performed with 5  µL of template using 
the QuantiTect Probe RT-PCR Kit (QIAGEN), primers 
and probes, and conditions as described elsewhere [11], 
with ROX as a reference dye.
All RT-qPCR analyses were performed using Agilent 
Mx3005P and Mx3000P qPCR-system (Agilent Tech-
nologies, Santa Clara, United States), and MxPro (v. 4.10) 
software, using the adaptive Baseline function. Cycle 
thresholds (Ct) were set manually to the same value in 
all the runs (dR = 380), in order to be able to compare Ct 
values among runs. Fish were considered virus positive at 
Ct levels below 35 and suspect between Ct 35–40; Ct val-
ues above 40 were negative.
Western blotting
Purified PRV-3 virus particles or blood pellets pooled 
from three cohabitant fish were mixed with XT buffer 
and XT reducing agent (Bio-rad), heated for 5  min at 
95 °C and loaded onto a 4–12% criterion XT bis–tris gel. 
Separated proteins were transferred onto a 0.2 µm PVDF 
membrane using Trans Blot Turbo Transfer system (Bio-
rad) and incubated overnight at 4  °C with antiserum 
against PRV-1 proteins; anti-σ1 (1:1000) [19], anti-σ3 
(1:500) [1], anti-µ1C (1:500) [19] and anti-actin (1:500) 
(Sigma). After washing 4 × 15 min the membranes were 
incubated with the secondary antibody horse radish per-
oxidase (HRP)-conjugated anti-rabbit IgG (Amersham, 
GE Healthcare, Buchinghamshire, UK) (1:20 000). The 
membranes were washed 4 × 15  min and stained with 
the Clarity Western ECL Substrate kit (Bio-rad). Magic-
Mark was used as molecular weight ladder (XP Western 
Protein Standard, Invitrogen). Images were acquired 
using ChemiDoc XRS+ system and Image one software 
(Bio-rad).
PRV immunoassay
The specific antibody response to PRV infection was 
measured as mean fluorescence intensity (MFI) in plasma 
samples of challenged rainbow trout using a bead based 
immunoassay as described earlier [20]. Briefly, plasma 
samples from cohabitant fish sampled from the the nega-
tive control, positive control and experimental groups 
were analysed for antibodies against µ1C. Beads, conju-
gated with and PRV-1 µ1C recombinant protein, were 
incubated with plasma harvested at 0, 4, 6, 8 and 10 wpc 
from cohabitants (n 6 per time point). The µ1C protein 
has 91.5% homology at the aminoacid level between 
PRV-1 and PRV-3 [13].
Histopathology
Hearts from 60 fish exposed to purified PRV particles 
and 60 fish from the positive control group were sampled 
at regular intervals and examined by histopathology; in 
addition, 20 hearts from the negative control group were 
assessed. Prior to exposure 9 fish were sampled and ana-
lysed as well (Table 1).
Tissue samples collected in 10% neutral-buffered for-
malin were embedded in paraffin and processed into sec-
tions of 3–4  μm, stained with haematoxylin and eosin 
(H&E) and examined by light microscopy. Pathological 
findings in the heart were classified as (1) mild (one to a 
few lesions), (2) moderate (more extended distribution of 
lesions) and (3) severe (most of the heart sample affected) 
[21].
Immune gene expression
In brief, tissues were homogenized in 650 µL QIAzol lysis 
reagent with 5  mm steel beads in a Tissue Lyser II for 
5 min. Following chloroform extraction, 350 µL of aque-
ous phase was loaded into an automated QIAcube (Qia-
gen) for RNA purification. Total RNA concentration was 
measured using a NanoDrop ND-1000 spectrophotom-
eter (Thermo Fisher Scientific). For gene expression anal-
ysis, cDNA was synthesized using 500  ng of total RNA 
using the QuantiTect Reverse Transcription kit (Qiagen) 
which includes a gDNA wipeout step. The qPCR was 
performed in duplicates with 10  ng of cDNA input in 
total volume of 10 µL per reaction using Maxima SYBR 
Green/ROX qPCR Master Mix (Fisher Scientific) and 
500 nM forward and reverse primers (Table 2). The assay 
included 95 °C for 10 min, 40 cycles of 94 °C for 15 s and 
60  °C for 30  s. The melting curve analysis confirmed 
the specificity of each SYBR qPCR assay, and elonga-
tion factor (EF1α) mRNA was used for normalization by 
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the ΔΔCt method. In Figures 3C, D and 5 all the PRV-3 
infected groups were compared to time-matched samples 
from negative control groups. At each time point, gene 
expression of fish exposed to purified PRV-3 particles 
and PRV-3 infected blood respectively were compared to 
the negative control at that specific time point. The fold 
changes in gene expression in the negative control group 
sampled at weeks 2, 4, 6, 8 and 10 were compared to the 
same group at week 0.
Statistical analysis
To assess the significant differences in immune gene 
expression between the control group and PRV-3 
infected groups, the statistical analysis was performed 
using one way ANOVA with Dunnets multiple com-
parison test [22]. The correlation between viral load and 
immune transcripts were done by non-parametric Spear-
man correlation test [23].
Results
Characterization of purified PRV-3
Purified PRV-3 particles were observed in TEM as spher-
ical, non-enveloped virions of approximately 75  nm in 
diameter resembling PRV-1 particles [3] (Figure 1A). No 
other type of virus particles were found. In western blot-
ting of purified virus, antibodies against PRV-1 σ1, σ3 
Table 2 Primers used for immune gene analysis 
Gene Primer sequences Amplicon length Reference Gene Bank No.
Elongation Factor (EF1a) GAT CCA GAA GGA GGT CAC CA
TTA CGT TCG ACC TTC CAT CC
150 [43] AF498320.1
Mx AGC TCA AAC GCC TGA TGA AG
ACC CCA CTG AAA CAC ACC TG
142 [43] NM_001171901
Viperin ACG ACC TCC AGC TCC CAA GT
GTC CAG GTG GCT CTT CCT GC
173 [43] AF076620.1
Interferon type 1 AAA ACT GTT TGA TGG GAA TAT GAA A
TGT TTC AGT CTC CTC TCA GGTT 
141 [43] NM_001124531
Interferon gamma CAA ACT GAA AGT CCA CTA TAA GAT CTCCA 
GGT CCA GCC TCT CCC TCA C
188 [44] FM864345.1
CD-4 CCT GCT CAT CCA CAG CCT AT
CTT CTC CTG GCT GTC TGA CC
111 [43] AY973030.1
CD-8 alpha AGT CGT GCA AAG TGG GAA AG
GGT TGC AAT GGC ATA CAG TG
123 [43] NM_001124263
Figure 1 Purified PRV-3 particles. A Transmission electron microscopy (TEM) of purified PRV-3 viral particles. B Western blot analysis of proteins 
from purified PRV-3 particles using antiserum raised against PRV-1 σ1, σ3 and µ1 proteins. Observed bands correspond to predicted full length 
proteins of 35 kDa, 37 kDA and 74 kDa, respectively.
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and µ1 recognized the corresponding proteins of PRV-3, 
observed as bands of 35, 37 and 74 kDa (Figure 1B).
PRV-3 RNA viral kinetics in heart and spleen
The PRV-3 RNA load in heart and spleen showed a simi-
lar trend for the positive control group, inoculated with 
PRV-3 infected blood, as for the group inoculated with 
purified PRV-3 particles. An acute phase characterized 
by a peak PRV-3 load was followed by virus clearance 
(Figures 2A and B).
In the positive control group (injected with PRV-3 
infected blood) viral RNA peaked at 2 wpc (median Ct 
26.8 in the heart and 22.5 in the spleen) while the peak 
occurred at 6 wpc in the cohabitants (median Ct 21 
in the heart and 18.1 in the spleen). In fish challenged 
with purified PRV-3, viral RNA peaked at 4 wpc in the 
injected group (median Ct 28.9 in the heart and 24.8 in 
the spleen) and at 6 wpc in the cohabitants (median Ct 25 
in the heart and 22.7 in the spleen).
After the peak phase of infection, the number of PRV 
positive fish per sampling point decreased and the Ct val-
ues of the positive fish increased, indicating viral clear-
ance. At the end of the trial (10 wpc) PRV-3 RNA could 
not be detected in the spleen or heart from shedders of 
the positive control group and only in three spleen and 
four heart samples from the six cohabitants. In virus-
positive samples, the Ct values were close to the set 
detection limit (Ct 35). A similar observation was made 
at 10 wpc in fish infected with purified PRV-3. No PRV-3 
RNA was detected in spleen samples from shedders, 
whereas the five positive out of six spleen samples from 
the cohabitants had high Ct values (> 29). Only one out 
of six heart samples from the shedders and five out of six 
from the cohabitants tested positive (Ct values > 30) at 10 
wpc. No PRV-3 was detected in samples from the nega-
tive control group.
No significant differences in haematocrit were 
observed between the groups (data not shown).
Histopathology
Histopathological findings in hearts consisting in the 
PRV-3 associated pathology described earlier [11, 12], 
were detected after peak load of PRV-3 in hearts in the 
respective groups. In the group challenged with purified 
PRV-3 particles, 2 shedders and 2 cohabitant fish had 
heart lesions, whereas 1 shedder and 7 cohabitants show 
Figure 2 PRV-3 infection kinetics. RT-qPCR of PRV-3 segment S1 in spleen and heart. Colored dots indicate Ct values of individual fish while 
horizontal bars show the median Ct value. Samples were considered virus positive at Ct levels below 35 and suspected between Ct 35-40 (grey 
shaded area); Ct values above 40 are negative. A Shedders (Blue) and cohabitants (red) in tank challenged with purified PRV-3 particles. B Shedders 
(green) and cohabitants (orange) in tank challenged with PRV-3 infected blood.
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heart pathology in the positive control group. Preva-
lence and distribution of heart lesions at each time point 
are shown in Table 3. The lesions observed were mild in 
fish infected with purified PRV-3 particles and mild to 
moderate in positive controls. Typical findings were epi-
carditis and focal to multifocal endo- and myocarditis 
in atrium and stratum spongiosum of the ventricle and 
perivasculitis and myocarditis in stratum compactum of 
the ventricle (Figures 3A and B). Histopathological find-
ings consisting of epicarditis and a focal inflammatory 
reaction involving the interface layer between stratum 
compactum and stratum spongiosum were occasion-
ally observed in all groups throughout the experiment 
(Additional file  1). Since they were clearly distinguish-
able from PRV-3 associated pathology, they were pruden-
tially removed while assessing the development of PRV-3 
pathology. 
PRV-3 protein detection
Western blot analysis of blood cells from cohabitants of 
fish injected with PRV-3 purified particles or infected 
blood, detected σ1 viral proteins at 6 wpc, correlating 
with the peak phase of infection. No viral proteins were 
detected in blood cells after 6 wpc (Figure 4A).
Development of specific antibodies against PRV
There was a significant increase in µ1C-specific IgM in 
plasma from PRV-3 infected cohabitant fish compared to 
plasma of uninfected fish at 8 wpc, and the production 
continued to increase at 10 wpc. Notably, large variations 
between individuals were observed (Figure 4B).
At 6 wpc the group challenged with PRV-3 infected 
blood had higher specific antibody levels than the 
purified PRV-3 particle group, but this was opposite at 10 
wpc.
Immune gene expression
The innate antiviral immune response following PRV-3 
infection was targeted by measuring Mx, Viperin, inter-
feron type 1 and interferon γ gene expression patterns in 
spleen. The T cell response in the heart was analyzed by 
targeting the T-cell markers CD4 and CD8. The Mx and 
Viperin gene expressions were significantly upregulated 
in the groups challenged with PRV-3 infected blood and 
purified virus particles, and correlated well with the viral 
load (Spearman r = 0.76) (Figure 5). In the shedders, the 
antiviral gene expression increased significantly along 
with the viral load at 2 wpc and 4 wpc, and subsided after 
4 wpc. In the cohabitants, the antiviral gene expression 
shows an acute peak at 6 wpc corresponding with the 
peak viral load. Both viral load and antiviral gene expres-
sion decreased after 6 wpc. In both cohabitant groups, 
CD4 and CD8 expression in heart remained equivalent to 
the 0 wpc control level until 8 wpc. The CD8 gene expres-
sion shows a particularly high increase (100-fold) peak-
ing at 10 wpc (Figures  3C  and D). The CD4 expression 
was also significantly higher at 10 wpc. The T cell marker 
gene expression did not correlate with the viral peak, but 
with the inflammation scores in the heart.
Discussion
The major aim of this study was to investigate an even-
tual association between PRV-3 infection in rainbow 
trout and the development of heart pathology consist-
ent with cardiac lesions observed in natural disease out-
breaks associated with PRV-3 infection. The detection 
of PRV-3 RNA in apparently healthy fish has raised 
Table 3 Prevalence and scores of histopathological findings in the hearts of PRV-3 challenged fish 
Proportion of positive fish per time point, histopathological score and Ct values of the positive hearts are given.
WPC PRV-3 purified particles PRV-3 infected blood
Shedder Score Ct Cohab. Score Ct Shedder Score Ct Cohab. Score Ct
2 0/6 0/6 0/6 0/6
4 0/6 0/6 0/6 0/6
6 1/6 1 29.5 0/6 0/6 0/6
8 0/6 0/6 0/6 2/6 1.5 21.8
1.5 22.8
10 1/6 1 > 35 2/6 1 31.2 1/6 1 > 35 5/6 1 32.7
1 30.1 1 32.7
1 > 35
1 31.7
1 36.8
Positive hearts 2 2 1 7
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questions in relation to the causative relationship 
between the virus and the disease. Koch’s postulates have 
historically defined the criteria to demonstrate a causa-
tive relationship between infecting agents and disease 
[24]. Fulfillment of Koch’s postulate relies on four main 
criteria, which are the presence of the disease agent in 
all disease cases; the possibility to isolate the agent in 
pure culture, the development of disease after the agent 
is inoculated in susceptible hosts and the re-isolation of 
the agent from the experimentally infected host. These 
criteria cannot be fulfilled for all disease-causing agents 
who resist culturing. According to the Rivers postulate, 
the viral agent should be isolated from a diseased individ-
ual and should induce the same disease when challenged 
with the purified viral inoculum as cell free extract and 
produce antibodies in a disease free individual of the 
same species [25]. The development of sequence based 
detection methods have led to further revision [26]. In 
recent years Atlantic salmon farming has in particular 
been challenged with a number of pathogens that resist 
cultivation [27] such as PRV-1 [3], piscine myocarditis 
virus (PMCV) [28, 29], and salmon gill poxvirus (SGPV) 
[30, 31]. The diagnostic investigations that followed the 
appearance of a new disease in farmed rainbow trout 
in Norway in 2013 [11] led to the detection of a virus 
with 80% gene sequence homology to PRV-1, and fur-
ther characterization of the virus concluded that it was 
a subtype of PRV, named PRV-3. Infectious trials were 
conducted to assess the risk associated with introduc-
tion of the new virus in salmonid aquaculture [12], which 
Figure 3 Histopathological findings and T-cell markers in the hearts of PRV-3 infected fish. A, B Rainbow trout infected with PRV-3 purified 
particles Epicarditis (long arrows) and inflammation in stratum compactum (outer layer) and stratum spongiosum (internal layer) of heart ventricle 
(arrow heads) (H&E). C Relative expression of the T-cell marker CD4 in the heart. The Ct values were normalized against control fish from 0 wpc. 
Significant differences compared to control are shown in asterisks *P < 0.05 **P < 0.001 and ***P < 0.0001. D Relative expression of the T-cell marker 
CD8 in the heart. The Ct values were normalized against control fish from 0 wpc. Significant differences compared to control are shown in asterisks 
*P <0.05 **P <0.001 and ***P <0.0001.
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indicated that the virus infects and replicates more effec-
tively in rainbow trout than in Atlantic salmon. PRV-3 
has been detected in several salmonid farming countries 
including Scotland, Germany, Italy, Denmark and Chile 
[13, 16, 17], but not always associated with clinical dis-
ease. Therefore, further investigations of the host–patho-
gen interaction could provide knowledge of benefit for 
fish health management.
The resistance of PRV to in vitro cultivation in available 
cell lines led to an approach where the virus was purified 
from experimentally infected fish as demonstrated by 
Wessel et  al. [3] for PRV-1 and by Takano et  al. [8] for 
PRV-2. Here, we adopted this approach by propagating 
PRV-3 in experimentally infected rainbow trout and puri-
fying the virus by density CsCl gradient ultracentrifuga-
tion, as described by Wessel et al. [3]. The purity of viral 
particles was confirmed by analyzing the fraction by Next 
Generation Sequencing-NGS [13]. In EM, PRV-3 parti-
cles show similar features to the one displayed by purified 
PRV-1, i.e. the spherical particles with icosahedral sym-
metry with a diameter of approximately 75 nm, and two 
concentric electron dense layers representing the double 
capsid (Figure 1A).
Notably, fish exposed to PRV-3 by cohabitation had 
higher viral loads than the injected groups, suggest-
ing that the cohabitation challenge model is suitable for 
investigation of PRV infection.
Fish challenged with purified PRV-3 by cohabitation 
were infected, as seen by the presence of σ1 protein at 6 
wpc as demonstrated by western blot of pelleted blood 
cells and by the increase of qPCR positive fish after 
cohabitation. The timing of this is similar to PRV-1 infec-
tion in Atlantic salmon [32].
PRV-1 establishes a persistent infection in Atlantic 
salmon, and viral RNA can be detected for at least 57 
wpc [33]. On the contrary, we observed that experimen-
tal PRV-3 infection in rainbow trout was characterized 
by significant clearance over time, in line with a previ-
ous study [12]. More specifically, the number of posi-
tive fish and virus levels per sampling point decreased 
after peak viremia. This trend of the infection kinetics 
was observed in both infected groups in our trial. In the 
positive control tank the injected fish reached peak virus 
levels already 2 wpc, whereas in the group injected with 
purified PRV-3 particles the peak was 4 wpc. Most likely, 
this difference can be explained by lower viral load in the 
initial inoculum, i.e. Ct 26.3 in PRV-3 infected blood, and 
Ct 32.67 in the purified PRV-3 inoculum.
The finding of PRV-specific antibody response from 
8 wpc directed against the outer capsid protein PRV-1 
µ1C showed that the infection was recognized by the fish 
humoral response. Temporally, PRV-specific antibodies 
were detectable 2 weeks following the peak viral load and 
presumably the main shedding period which occurred at 
6 wpc in cohabitants.
PRV-3 infection in rainbow trout did not cause reduced 
survival, neither in the positive control group nor in the 
group challenged with purified PRV-3 particles, consist-
ent with what is previously observed under experimental 
conditions [12].
PRV-3 challenged fish developed typical heart pathol-
ogy; a pancarditis, where all parts of the heart were 
Figure 4 PRV-3 proteins in blood cells and anti-PRV-3 antibodies in plasma. A Western blot analysis of blood cell pellets from cohabitants to 
purified PRV-3 injected fish. B Multiplex analysis of PRV-3 µ1c specific antibodies in cohabitant fish measured in Mean fluorescence intensity (MFI). 
Six fish were tested per sampling and group.
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Figure 5 Innate antiviral immune gene expression in spleen of PRV-3 challenged fish. Relative expression of IFN1, IFNγ, Mx, and Viperin in 
controls, pure virus injected fish, blood pellet injected fish and their respective cohabitant groups (n = 6). The Ct values were normalized against 
control fish from 0 wpc. Significant differences compared to control are shown in asterisks *P <0.05 **P <0.01, ***P <0.001, ****P <0.0001.
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affected. This was more pronounced in fish challenged 
with PRV-3 infected blood, nevertheless fish exposed 
to purified PRV-3 particles had these heart lesions. 
Although mild, the histopathological findings in the 
experimental group were consistent with a pathology 
described in field cases [11], from previous experiments 
[12] and the same as observed in the positive control 
group in this study.
An attempt to stain PRV antigen by immunohisto-
chemistry in heart sections from fish with high viral loads 
with a polyclonal antibody against PRV-1 failed. This 
could be explained by low sensitivity of the antibodies 
in IHC, i.e. the amount of viral antigen was too low for 
detection. Another explanation could be conformational 
differences between PRV-1 and PRV-3. PRV-3 antigen 
can be detected in western blots under denaturing con-
ditions, but it highlights the need for development of 
specific tools for identifying the localization of PRV-3 in 
tissue.
Our results linked the presence of the virus to the 
consecutive development of pathology in the heart, 
but furthermore also to the upregulation of CD8 and 
CD4 lymphocyte markers in this organ. The PRV-3 
load peaked at 6 wpc in cohabitants, 4 weeks before the 
increased expression of CD8+ T cell population marker 
in the heart.
The increased level of the CD8+ T cell transcripts 
was associated with the observation of heart pathol-
ogy, as previously observed in Atlantic salmon [32, 34]. 
This finding strengthens the link between CD8+ cyto-
toxic cells and heart inflammation, and indicates that the 
mechanisms of Norwegian PRV-1 induced HSMI [34] 
is paralleled by the pathogenesis of the PRV-3 induced 
heart pathology. The study highlighted some similarities 
between PRV-1 infection in Atlantic salmon and PRV-3 
infection in rainbow trout. The two viral subtypes shares 
80% homology at the genetic level [13], they target the 
respective host erythrocytes for replication and cause 
similar inflammatory lesion in the heart of infected fish. 
Both viral subtypes trigger similar immune responses 
in the respective hosts. Conversely, PRV-1 establishes a 
persistent infection in Atlantic salmon while our findings 
indicate that PRV-3 infection could be of limited duration 
in rainbow trout. Notably, PRV-3 affected rainbow trout 
in field outbreaks suffer severe anaemia [11], which is not 
reported for HSMI in Atlantic salmon. Furthermore typi-
cal PRV-3 outbreaks in rainbow trout occurred in fresh 
water, whereas HSMI is most common after sea transfer.
The innate antiviral gene regulation in the present 
study followed the PRV-3 kinetics, thus strengthening 
the association between PRV load and innate antiviral 
responses in infected salmonids [3, 12, 34, 35]. The innate 
antiviral gene upregulation in the early stage of PRV-3 
infection may efficiently hamper the progression of viral 
infection, and lead to the decreased viral load after 6 
wpc. Differences have been observed for HSMI and in 
innate antiviral response after PRV-1 challenge of Atlan-
tic salmon indicating that viral and/or host genetic fac-
tors influence the outcome of a PRV-1 infection [3, 33]. 
For Mammalian orthoreovirus it has been shown that the 
ability to induce IFN contributes to the differences in the 
development of myocarditis [36, 37].
Previous studies [12] have shown how experimental 
infection in Atlantic salmon with PRV-3 infected blood 
failed to induce host innate immune response. Moreover, 
experimental infection in sockeye salmon (Oncorhyn-
chus nerka) with PRV-1 fail to induce IFN related genes 
[38], whereas PRV-1 infection successfully trigger IFN 
related immune response modulating the susceptibility 
of Atlantic salmon to subsequent challenge with Infec-
tious haematopoietic necrosis virus—IHNV or Salmonid 
alphavirus—SAV [35, 39, 40].
PRV infection of farmed salmonids can broadly be 
divided into two different clinical manifestations. (1) An 
acute disease, EIBS, which is a direct consequence of 
severe anemia at the peak of viremia, as seen in PRV-2 
infection of coho salmon. It could be speculated that 
the jaundice syndrome described in Chinook salmon 
(related to PRV-1) [41] and jaundice syndrome reported 
in coho salmon (related to PRV-3) [16, 17] are down-
stream consequences of the clearance process of infected 
erythrocytes. Yet the role of PRV-1 and PRV-3 in the 
development of anaemia remains unknown. PRV-1 infec-
tion under experimental conditions failed to induce 
anaemia in Sockeye salmon [33, 38]. In Atlantic salmon, 
experimental infection with PRV-1 has only occasionally 
led to reduction of haematocrit and haemoglobin lev-
els [35]. Notably, in this study, high loads of PRV-3 were 
generated in rainbow trout without causing a reduction 
of haematocrit, albeit it is described in disease outbreaks 
associated with PRV-3 in the field [11]. These findings 
might suggest that other factors, possibly related to farm-
ing conditions, are involved in the development of anae-
mia in clinical outbreaks. (2) HSMI, which appears a few 
weeks after the viraemia peak as demonstrated for PRV-1 
in Atlantic salmon, is characterized by inflammation seen 
as influx of CD8 lymphocytes in heart tissue [34, 42]. In 
field outbreaks associated with PRV-3 reported by Olsen 
et  al. [11], 113 fish were examined for histopathology. 
Amongst these, 80 fish showed evident clinical signs and 
33 apparently looked healthy. A heart pathology resem-
bling HSMI was described in 103 of the 113 fish exam-
ined [11]. In the current study, no clinical signs were 
observed, and an HSMI-like pathology was observed in 
a limited number of fish. Yet, in line with the timing of 
observation of heart pathology after PRV-1 infection in 
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Atlantic salmon [19], the HSMI related histopathologi-
cal findings in the heart in the present experiment were 
observed in the later stage of the trial, i.e. at 6 wpc in the 
injected group and 10 wpc in the cohabitant group.
In conclusion, the findings of this study support the 
hypothesis that establishes the causative relationship 
between PRV-3 infection in rainbow trout and the devel-
opment of pancarditis as described for HSMI in Atlantic 
salmon. Furthermore, the identification of the aetiologi-
cal agent, makes a basis for the development of specific 
preventive tools and control strategies. The recent emer-
gence of PRV-3 variants in rainbow trout farms associ-
ated with severe disease outbreaks [13], warrants further 
investigation in search of factors that modulate the sever-
ity of the disease.
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